Shares of Eastman Kodak (NYSE: KODK) plunged on Monday, as the volatile small-cap stock surrendered much of its recent gains. As of 3:35 p.m. EDT, Kodak's stock price was down more than 30%.
Following news that it had secured a $765 million Defense Production Act loan to produce COVID-related pharmaceutical components, Eastman Kodak's shares soared as much as 2,757%. From its closing price of $2.10 on July 24, Kodak's stock price hit a high of $60 on July 29.
Kodak's stock, however, has pulled back violently since then. With its shares currently trading for about $15, Kodak has shed roughly three-quarters of its value from its recent highs.
Questions are swirling as to why Kodak, which is primarily a technology company, was chosen to receive a loan related to pharmaceutical supplies, rather than a company with more experience in the field. Kodak's board of directors also made the questionable decision to grant executive chairman Jim Continenza options for 1.75 million shares of stock just before the deal was announced. Additionally, Kodak's convertible debtholders have chosen to convert their bonds into stock, which, while helping to strengthen the company's balance sheet, is diluting existing shareholders.
In light of these factors, most investors would likely be best served by staying clear of Eastman Kodak's stock.
10 stocks we like better than Eastman Kodak
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Eastman Kodak wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 2, 2020
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.